Abstract
Plant endophytic fungi are considered an important source of natural bioactive compounds which commonly applied in agriculture, medicine, and food industry. In the past two decades, many valuable bioactive secondary metabolites obtained from the endophytic fungi have antimicrobial, insecticidal, cytotoxic and anticancer activities. Many recent articles revealed endophyte natural products as new compounds and discussed their biological activities and source organisms, as well as the plant sources.
Keywords: Anticancer, antimalarial, azaphilones, biological activities, endophytic fungi, fungal metabolites, novel natural products, secondary metabolites, Anticancer products, novel natural, endophyte, renewable source.
The Natural Products Journal
Title:Plant Endophytes, Renewable Source of New Natural Products
Volume: 2 Issue: 3
Author(s): Ehab S. El-Khayat, Sabrin R. Mohamed Ibrahim and Gamal A. Mohamed
Affiliation:
Keywords: Anticancer, antimalarial, azaphilones, biological activities, endophytic fungi, fungal metabolites, novel natural products, secondary metabolites, Anticancer products, novel natural, endophyte, renewable source.
Abstract: Plant endophytic fungi are considered an important source of natural bioactive compounds which commonly applied in agriculture, medicine, and food industry. In the past two decades, many valuable bioactive secondary metabolites obtained from the endophytic fungi have antimicrobial, insecticidal, cytotoxic and anticancer activities. Many recent articles revealed endophyte natural products as new compounds and discussed their biological activities and source organisms, as well as the plant sources.
Export Options
About this article
Cite this article as:
S. El-Khayat Ehab, R. Mohamed Ibrahim Sabrin and A. Mohamed Gamal, Plant Endophytes, Renewable Source of New Natural Products, The Natural Products Journal 2012; 2 (3) . https://dx.doi.org/10.2174/2210315511202030225
DOI https://dx.doi.org/10.2174/2210315511202030225 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Toxic Metals in Herbal Medicines. A Review
Current Bioactive Compounds Design and Synthesis of 4(1H)-quinolone Derivatives as Autophagy Inducing Agents by Targeting ATG5 Protein
Letters in Drug Design & Discovery Molecular Pathologies of and Enzyme Replacement Therapies for Lysosomal Diseases
CNS & Neurological Disorders - Drug Targets Off-Label Use of Sunitinib in Patients with Advanced, Epithelial Thyroid Cancer: A Retrospective Analysis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Mechanisms of Corticosteroid Resistance in Severe Asthma and Chronic Obstructive Pulmonary Disease (COPD)
Current Pharmaceutical Design Modular Nanotransporters for Targeted Intracellular Delivery of Drugs: Folate Receptors as Potential Targets
Current Pharmaceutical Design Cigarette Smoking, Metabolic Activation and Carcinogenesis
Current Drug Metabolism Therapeutic Outlook of Pyrazole Analogs: A Mini Review
Mini-Reviews in Medicinal Chemistry NK-1 Receptor Antagonists: A New Paradigm in Pharmacological Therapy
Current Medicinal Chemistry Antioxidant and Anti-proliferative Activities of Astaxanthin Extracted from the Shell Waste of Deep-water Pink Shrimp (Parapenaeus longirostris)
The Natural Products Journal Drug Targets in Cytomegalovirus Infection
Infectious Disorders - Drug Targets Clinical Analysis Methods of Voice Disorders
Current Bioinformatics Antimicrobial Peptides in Oral Cancer
Current Pharmaceutical Design Perspectives on Adipose-Derived Stem/Stromal Cells as Potential Treatment for Scarred Vocal Folds: Opportunity and Challenges
Current Stem Cell Research & Therapy Conventional Anticancer Therapeutics and Telomere Maintenance Mechanisms
Current Pharmaceutical Design Advancing Drug Therapy for Brain Tumours: A Current Review of the Pro-inflammatory Peptide Substance P and its Antagonists as Anti-cancer Agents
Recent Patents on CNS Drug Discovery (Discontinued) Stat3 Orchestrates Tumor Development and Progression: The Achilles Heel of Head and Neck Cancers?
Current Cancer Drug Targets Regulation of Tumor Immune Microenvironment by Sphingolipids and Lysophosphatidic Acid
Current Drug Targets Malignant Mesothelioma: Biology, Diagnosis and Therapeutic Approaches
Current Molecular Pharmacology Molecular Targeted Therapies in the Management of Head and Neck Squamous Cell Carcinoma: Recent Developments and Perspectives
Anti-Cancer Agents in Medicinal Chemistry